Sort
82,697 grants matching “vaccine development”
Project 5: mAb Development Flaviviruses and Alphaviruses
$5,594,501James E Crowe · Washington University · U19 · FY2024 · AI
DEVELOPMENT OF A STAPHYLOCOCCUS AUREUS ? CANDIDA SP. VACCINE
$5,594,000Novadigm Therapeutics, Inc. · · FY2011 · Department of Defense
HIV/AIDS Vaccine Development
$5,585,016John Mascola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
HIV Preventive Vaccine and Monoclonal Antibody Studies
$5,562,116Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
HIV Preventive Vaccine Studies
$5,562,116Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
SDMC - IMPAACT Leadership Group
$5,560,743David Eric Shapiro · Harvard School Of Public Health · UM1 · FY2015 · AI
Consortium for Immunotherapeutics Against Viral Hemorrhagic Fevers
$5,557,936Erica Ollmann Saphire · Scripps Research Institute, The · U19 · FY2015 · AI
BELIEVE: Bench to Bed Enhanced Lymphocyte Infusions to Engineer Viral Eradication
$5,555,460Douglas F Nixon · Weill Medical Coll Of Cornell Univ · UM1 · FY2019 · AI
EXTERNAL QUALITY ASSURANCE PROGRAM OVERSIGHT LABORATORY
$5,553,860Marianne Ward · Duke University · N01 · FY2016 · AI
Delaney AIDS Research Enterprise to Cure HIV
$5,547,114Steven Grant Deeks · University Of California, San Francisco · UM1 · FY2016 · AI
Delaney AIDS Research Enterprise to Cure HIV
$5,547,114Steven Grant Deeks · University Of California, San Francisco · UM1 · FY2018 · AI
Delaney AIDS Research Enterprise to Cure HIV
$5,544,984Steven Grant Deeks · University Of California, San Francisco · UM1 · FY2020 · AI
HIV Vaccine Studies
$5,541,919Lesia K Dropulic · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Development of a Nanoemulsion Adjuvant with a Vaccine for Pandemic Influenza
$5,516,166Ali I. Fattom · Bluewillow Biologics, Inc. · N01 · FY2013 · AI
HIV VACCINE TRIALS NETWORK LEADERSHIP GROUP
$5,513,907Fred Hutchinson Cancer Research Center · U01 · FY2004 · AI
23rd International AIDS Conference (AIDS 2020), San Francisco and Oakland, United States, 6-10 July 2020
$5,507,940Chris Beyrer · Ias · R13 · FY2020 · AI
Novel adjuvants acting through TLR2, TLR5 and TLR7 receptors
$5,505,977Sunil David · University Of Kansas Lawrence · N01 · FY2009 · AI
Duke Center for HIV Structural Biology
$5,505,134Priyamvada Acharya · Duke University · U54 · FY2022 · AI
DEVELOPMENT OF UM-1098: A NOVEL SYNTHETIC TH17 INDUCING ADJUVANT AND DELIVERY SYSTEM
$5,504,851Jay Evans · University Of Montana · N01 · FY2024 · AI
cGMP Production of a HCMV gag (P4) prototype HIV vaccine candidate
$5,496,857Timothy Fouts · Advanced Bioscience Laboratories, Inc. · N01 · FY2019 · AI
Emory- Duke- Orlando- CDC (EmDOC) Clinical Trials Unit
$5,493,765Jeffrey Lennox · Emory University · UM1 · FY2019 · AI
Delaney AIDS Research Enterprise to Cure HIV
$5,493,761Steven Grant Deeks · University Of California, San Francisco · UM1 · FY2017 · AI
Core--Vector
$5,492,013Jaap Goudsmit · Beth Israel Deaconess Medical Center · U19 · FY2006 · AI
Development of Adjuvant with Vaccines for Tuberculosis and Shigellosis
$5,490,179Kathlenn Kozar · Tulane University · N01 · FY2013 · AI
Duke Center for HIV Structural Biology
$5,488,457Priyamvada Acharya · Duke University · U54 · FY2023 · AI